Sign up to save your podcasts
Or
Share WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
CME credits: 1.25
Valid until: 27-03-2024
Claim your CME credit at https://reachmd.com/programs/cme/who-characterizing-vericiguat-use-in-a-real-world-hfref-patient-population/15288/
In this program, expert faculty discuss data presented at the 2023 ACC Congress in a concise, informative, on-demand format. This format extends the congress analysis to a broader audience with greater detail than what is available in abstracts. Rapid advances from the meeting require well-planned educational programming to bridge knowledge, competence, and performance gaps.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.25
Valid until: 27-03-2024
Claim your CME credit at https://reachmd.com/programs/cme/who-characterizing-vericiguat-use-in-a-real-world-hfref-patient-population/15288/
In this program, expert faculty discuss data presented at the 2023 ACC Congress in a concise, informative, on-demand format. This format extends the congress analysis to a broader audience with greater detail than what is available in abstracts. Rapid advances from the meeting require well-planned educational programming to bridge knowledge, competence, and performance gaps.